Latest News about URGN
Recent news which mentions URGN
The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation
July 23, 2019
From Benzinga
The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership
June 25, 2019
From Benzinga
The Daily Biotech Pulse: Merrimack To Stay Independent, Chinese Cheer For Beigene, XBiotech Offering
May 31, 2019
From Benzinga
Benzinga's Top Upgrades, Downgrades For May 30, 2019
May 30, 2019
From Benzinga
3 Top Stocks That Aren't on Wall Street's Radar
May 26, 2019
From Motley Fool
From Motley Fool
Tickers
URGN
From Motley Fool
The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stock To Debut
May 09, 2019
From Benzinga
From Benzinga
3 International Companies Making Waves in the U.S. Soon
April 20, 2019
From Motley Fool
From Motley Fool
The Daily Biotech Pulse: Tonix Gets European Patent, EC Nod For Roche, Insys Earnings
March 07, 2019
From Benzinga
Daily Biotech Pulse: Allergan's Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO
March 06, 2019
From Benzinga
UroGen Pharma Ltd. (URGN) Q4 2018 Earnings Conference Call Transcript
February 28, 2019
Tickers
URGN
From Motley Fool
The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems
February 28, 2019
From Benzinga
From Motley Fool
Benzinga's Top Upgrades, Downgrades For January 29, 2019
January 29, 2019
From Benzinga
62 Biggest Movers From Yesterday
January 24, 2019
From Benzinga
51 Stocks Moving In Thursday's Mid-Day Session
January 24, 2019
From Benzinga
35 Stocks Moving In Thursday's Pre-Market Session
January 24, 2019
From Benzinga
The Daily Biotech Pulse: Partial Clinical Hold On Advaxis Cervical Cancer Drug, Ohr's Reverse Split, Ironwood Starts Phase 1 Trial
January 23, 2019
From Benzinga
54 Biggest Movers From Yesterday
January 23, 2019
From Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
January 23, 2019
From Benzinga
The Daily Biotech Pulse: PTC Therapeutics, Select Biosciences Offering, Unity Biotech Expands Early-Stage Osteoporosis Drug Study
January 22, 2019
From Benzinga
22 Stocks Moving In Wednesday's Pre-Market Session
January 09, 2019
From Benzinga
58 Biggest Movers From Yesterday
January 08, 2019
From Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
January 08, 2019
From Benzinga
The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs
November 11, 2018
From Benzinga
Tickers
URGN
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.